Combining Chemoradiotherapy With Sintilimab in First-Line ICC
Clinical trial NCT06447454 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06447454
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-12-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.